275 related articles for article (PubMed ID: 30692568)
1. Data-Driven Subtyping of Parkinson's Disease Using Longitudinal Clinical Records: A Cohort Study.
Zhang X; Chou J; Liang J; Xiao C; Zhao Y; Sarva H; Henchcliffe C; Wang F
Sci Rep; 2019 Jan; 9(1):797. PubMed ID: 30692568
[TBL] [Abstract][Full Text] [Related]
2. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
[TBL] [Abstract][Full Text] [Related]
3. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
[TBL] [Abstract][Full Text] [Related]
4. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes.
Fereshtehnejad SM; Romenets SR; Anang JB; Latreille V; Gagnon JF; Postuma RB
JAMA Neurol; 2015 Aug; 72(8):863-73. PubMed ID: 26076039
[TBL] [Abstract][Full Text] [Related]
5. Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology.
Boertien JM; van der Zee S; Chrysou A; Gerritsen MJJ; Jansonius NM; Spikman JM; van Laar T;
BMC Neurol; 2020 Jun; 20(1):245. PubMed ID: 32534583
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors of Rapid symptoms progression in patients with newly diagnosed parkinson's disease.
Tsiouris KM; Konitsiotis S; Koutsouris DD; Fotiadis DI
Artif Intell Med; 2020 Mar; 103():101807. PubMed ID: 32143804
[TBL] [Abstract][Full Text] [Related]
7. COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015), a global--clinical evaluations, serum biomarkers, genetic studies and neuroimaging--prospective, multicenter, non-interventional, long-term study on Parkinson's disease progression.
Santos-García D; Mir P; Cubo E; Vela L; Rodríguez-Oroz MC; Martí MJ; Arbelo JM; Infante J; Kulisevsky J; Martínez-Martín P;
BMC Neurol; 2016 Feb; 16():26. PubMed ID: 26911448
[TBL] [Abstract][Full Text] [Related]
8. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
[TBL] [Abstract][Full Text] [Related]
9. Does the MDS-UPDRS provide the precision to assess progression in early Parkinson's disease? Learnings from the Parkinson's progression marker initiative cohort.
Regnault A; Boroojerdi B; Meunier J; Bani M; Morel T; Cano S
J Neurol; 2019 Aug; 266(8):1927-1936. PubMed ID: 31073716
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant connectivity features define three subtypes of Parkinson's disease patients.
Guo T; Guan X; Zhou C; Gao T; Wu J; Song Z; Xuan M; Gu Q; Huang P; Pu J; Zhang B; Cui F; Xia S; Xu X; Zhang M
Hum Brain Mapp; 2020 Oct; 41(14):4077-4092. PubMed ID: 32588952
[TBL] [Abstract][Full Text] [Related]
11. A data-driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes.
Graham JM; Sagar HJ
Mov Disord; 1999 Jan; 14(1):10-20. PubMed ID: 9918339
[TBL] [Abstract][Full Text] [Related]
12. Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
Simuni T; Caspell-Garcia C; Coffey CS; Weintraub D; Mollenhauer B; Lasch S; Tanner CM; Jennings D; Kieburtz K; Chahine LM; Marek K
J Neurol Neurosurg Psychiatry; 2018 Jan; 89(1):78-88. PubMed ID: 28986467
[TBL] [Abstract][Full Text] [Related]
13. Distinct progression patterns across Parkinson disease clinical subtypes.
Myers PS; Jackson JJ; Clover AK; Lessov-Schlaggar CN; Foster ER; Maiti B; Perlmutter JS; Campbell MC
Ann Clin Transl Neurol; 2021 Aug; 8(8):1695-1708. PubMed ID: 34310084
[TBL] [Abstract][Full Text] [Related]
14. Non-motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life.
Huang X; Ng SY; Chia NS; Setiawan F; Tay KY; Au WL; Tan EK; Tan LC
Eur J Neurol; 2019 Mar; 26(3):400-406. PubMed ID: 30175887
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning.
Severson KA; Chahine LM; Smolensky LA; Dhuliawala M; Frasier M; Ng K; Ghosh S; Hu J
Lancet Digit Health; 2021 Sep; 3(9):e555-e564. PubMed ID: 34334334
[TBL] [Abstract][Full Text] [Related]
16. Unraveling Parkinson's disease heterogeneity using subtypes based on multimodal data.
Albrecht F; Poulakis K; Freidle M; Johansson H; Ekman U; Volpe G; Westman E; Pereira JB; Franzén E
Parkinsonism Relat Disord; 2022 Sep; 102():19-29. PubMed ID: 35932584
[TBL] [Abstract][Full Text] [Related]
17. Clinical subtypes of Parkinson's disease.
van Rooden SM; Colas F; Martínez-Martín P; Visser M; Verbaan D; Marinus J; Chaudhuri RK; Kok JN; van Hilten JJ
Mov Disord; 2011 Jan; 26(1):51-8. PubMed ID: 21322019
[TBL] [Abstract][Full Text] [Related]
18. Olfactory impairment predicts cognitive decline in early Parkinson's disease.
Fullard ME; Tran B; Xie SX; Toledo JB; Scordia C; Linder C; Purri R; Weintraub D; Duda JE; Chahine LM; Morley JF
Parkinsonism Relat Disord; 2016 Apr; 25():45-51. PubMed ID: 26923521
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive subtyping of Parkinson's disease patients with similarity fusion: a case study with BioFIND data.
Brendel M; Su C; Hou Y; Henchcliffe C; Wang F
NPJ Parkinsons Dis; 2021 Sep; 7(1):83. PubMed ID: 34535682
[TBL] [Abstract][Full Text] [Related]
20. Parkinson disease clinical subtypes: key features & clinical milestones.
Campbell MC; Myers PS; Weigand AJ; Foster ER; Cairns NJ; Jackson JJ; Lessov-Schlaggar CN; Perlmutter JS
Ann Clin Transl Neurol; 2020 Aug; 7(8):1272-1283. PubMed ID: 32602253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
